MedTrace Logo

Monitoring the IMmUological TOXicity of Drugs

NCT03480529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 662

Last updated 2019-09-04

No results posted yet for this study

Summary

Several drugs and chemotherapies seem to have an impact on the immunological system. This study investigates reports of immunological toxicities, including the International classification of disease ICD-10 codes M05, M32, I78 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

Conditions

Interventions

DRUG

drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom

Drugs susceptible to induce arthritis, lupus, hepatitis, or capillary leak syndrom

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Groupe Hospitalier Pitie-Salpetriere

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-03-10
Completion
2018-03-10
FDA Drug
Yes

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480529 on ClinicalTrials.gov